名媛直播

Seed oils (sunflower, sesame, etc.) are not driving the surge in . (Science Feedback)

Only 4% of men with an elevated PSA but a normal MRI 3 years later, offering a biopsy-sparing approach. (JAMA Oncology)

Ten biotech companies expected to be at the forefront of . (Labiotech)

Affimed announced positive results of a single-arm study of 50 patients with heavily pretreated treated with atezolizumab (Tecentriq) and the bispecific immune-cell engager AFM24.

Primary radiotherapy achieved a 91% local control rate in at 3 years. (Journal of the National Comprehensive Cancer Network)

A diet low in omega-6 and enriched with omega-3 fatty acids and fish oil for prostate cancer patients on active surveillance was associated with a . (UCLA Health, Journal of Clinical Oncology)

Adding the PD-1 inhibitor dostarlimab (Jemperli) to platinum-based chemotherapy and niraparib (Zejula) maintenance therapy significantly improved progression-free survival in , GSK announced.

The American Cancer Society reviews some of the in cancer prevention, detection, treatment, and survival.

Meanwhile, cancer experts look into their crystal ball to predict . (Mass General Brigham)

The FDA granted to encorafenib (Braftovi) plus cetuximab (Erbitux) and FOLFOX6 chemotherapy for metastatic BRAF V600E-mutant colorectal cancer.

Responding to the growing problem of cardiovascular side effects of cancer treatment, the European Society of Cardiology announced the inaugural meeting, to be held June 20-21 in Florence, Italy, the first of what is expected to be an annual meeting for cardio-oncology specialists.

A blood test involving artificial intelligence-supported laser analysis exhibited high accuracy for detecting and its molecular subtypes, which could enable more personalized treatment at the earliest stages. (University of Edinburgh, Journal of Biophotonics)

Comment